RecruitingNCT06436053
Acute Response to Left Bundle Branch Area Pacing With SyncAV
Sponsor
Abbott Medical Devices
Enrollment
50 participants
Start Date
May 15, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This clinical investigation is a prospective, single-arm, post-market, non-randomized, single-center study designed to evaluate the effectiveness of the SyncAV CRT dynamic atrioventricular (AV) delay feature when used with left bundle branch area pacing (LBBAP).
Eligibility
Min Age: 18 Years
Inclusion Criteria5
- Patient is 18 years of age and willing to comply with the study requirements
- Patients with approved indication for dual-chamber pacing or cardiac resynchronization therapy and scheduled to be implanted with an Abbott pacing system
- Patient has documented left bundle branch block (LBBB) or intraventricular conduction delay (IVCD)
- Patient has an intrinsic QRS duration ≥ 130 ms
- Patient has intact AV conduction with PR interval ≤ 250 ms
Exclusion Criteria9
- Patient has a resting ventricular rate \> 100 bpm
- Patient has AV Block (2nd or 3rd degree)
- Patient has documented persistent atrial tachycardia or atrial fibrillation
- Patient has had a recent myocardial infarction, ablation, electrolyte imbalance, or any condition within the last 90 days that would contraindicate for pacing device programming changes in the opinion of the investigator
- Patient is currently participating in another clinical investigation
- Patient is pregnant or nursing
- Patient has other medical, anatomic, comorbid, social, or psychological conditions that, in the investigator's opinion, could limit the subject's ability to participate in the clinical investigation or to comply with follow-up requirements, or impact the scientific soundness of the clinical investigation results
- Patient does not have legal authority
- Patient is unable to read or write
Interventions
DEVICELBBAP with SyncAV
Acute changes in surface ECG QRS duration resulting from left bundle branch area pacing using various pacing configurations will be evaluated.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06436053
Related Trials
Mind Your Heart-II
NCT054311921 location
Timing of Coronary Angiography in NSTEMI Complicated by Acute HF
NCT0700216420 locations
ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies
NCT071917301 location
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
NCT06424288652 locations
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
NCT06935370641 locations